Advancing Cell & Gene Therapies Together: Thank You from the Summit

Precision medicine is no longer just a scientific capability; it is a systemic challenge that requires us to work at pace. We recently had the privilege of exploring this at the Cell & Gene Therapy Summit, proudly co-hosted with ARCS Australia and the Drug Information Association (DIA).

We were deeply honoured to co-chair the Access & Equity session and learn from a brilliant lineup of national and international leaders.

Key takeaways from our discussions:

• Collaboration as the operating model: Consortia, coordinated national action, and public-private partnerships are how we ensure precision medicine becomes accessible, rather than exceptional.
• Global harmonisation: A unified focus on the 3 Pillar Framework: Alignment, Standards, and Enable.
• Quality by design: Relying on shared platforms and reusable building blocks to ensure speed, consistency, and scale for individualised therapies.

A profound thank you goes to the patients and advocates who grounded our conversations. Your stories are the ultimate reminder of why urgency and coordination matter.

Finally, a massive thank you to our expert speakers and our incredible collaborators on the programming committee: Anna Megalakakis, Navinisha Lee, Tamei Elliott, Maria Vassileva, Dr. Marguerite Evans-Galea AM, Lesbeth Rodrigez, James Wabby, and Young Joo. Together, you helped shape a conversation our ecosystem urgently needs.

Stay tuned: we look forward to publishing a comprehensive report on the summit’s key themes very soon!